Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

Bank of Montreal

Bank of Montreal Raises $50B in Public

129 Rue Saint-Jacques, Montreal, QC H2Y 1L6, CanadaJanuary 1, 20242 min read
Employees
45000+

Bank of Montreal Raises $50B in Public


Bank of Montreal has successfully raised $50B in a Public at a $55B valuation led by Public.


Company Overview


Bank of Montreal is a Banking company headquartered in 129 Rue Saint-Jacques, Montreal, QC H2Y 1L6, Canada, founded in 1817 with 45000+ employees.


Canadian multinational bank


Fundraising Details


  • Amount Raised: $50B
  • Round Type: Public
  • Valuation: $55B
  • Date: 2024-01-01
  • Investors: Public

About Bank of Montreal


Canadian multinational bank The company is positioned in the Banking sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 129 Rue Saint-Jacques, Montreal, QC H2Y 1L6, Canada
  • Founded: 1817
  • Team Size: 45000+
  • Industry: Banking

What This Means


This funding round demonstrates strong investor confidence in Bank of Montreal's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Banking sector continues to attract significant investment as companies innovate to meet evolving market demands. Bank of Montreal's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $55B valuation marks an important milestone for Bank of Montreal, positioning the company among notable players in the Banking industry.


Looking Ahead


With this new capital, Bank of Montreal is well-positioned to execute on its growth strategy and continue building innovative solutions in the Banking space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Bank of Montreal, visit their headquarters at 129 Rue Saint-Jacques, Montreal, QC H2Y 1L6, Canada.

Company Info

Headquarters
129 Rue Saint-Jacques, Montreal, QC H2Y 1L6, Canada
Founded
1817
Team Size
45000+

Topics

Fundraising(2912)Public(771)BankingBank of Montreal

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free